(Il Sole 24 Ore Radiocor) - Milano, 23 apr - Thermo Fisher Scientific, a US provider of medical equipment and services, said that in the first quarter of 2026 diluted earnings per share (EPS) grew 11% year on year to 4.43 dollars and adjusted EPS rose 6% to 5.44 dollars.

Revenue increased 6% to 11.01 billion dollars.

'Looking ahead, we are well positioned to deliver a strong year," said.

Marc Casper, the chairman and chief executive officer.

(RADIOCOR) 23-04-26 12:29:57 (0391) 5 NNNN